D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
GE Vernova
GEV
|
+$601M |
| 2 |
Walt Disney
DIS
|
+$510M |
| 3 |
Palantir
PLTR
|
+$502M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$490M |
| 5 |
TSMC
TSM
|
+$396M |
Top Sells
| 1 |
Boeing
BA
|
+$967M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$567M |
| 4 |
Eli Lilly
LLY
|
+$551M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| 1 | Technology | 20.32% |
| 2 | Healthcare | 13% |
| 3 | Consumer Discretionary | 12.32% |
| 4 | Financials | 8.62% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Fortis
FTS
$24.8B
| $888K | ﹤0.01% |
19,500
-48,360
| -71% | -$2.2M |
|
2102
Navitas Semiconductor
NVTS
$1.32B
| $885K | ﹤0.01% |
431,608
+406,367
| +1,610% | +$833K |
|
2103
Alerian MLP ETF
AMLP
$10.5B
| $884K | ﹤0.01% |
17,015
-482,652
| -97% | -$25.1M |
|
|
TRTX
2104
TPG RE Finance Trust
TRTX
$739M
| $878K | ﹤0.01% |
107,692
-282,213
| -72% | -$2.3M |
|
2105
Healthcare Realty
HR
$6.45B
| $875K | ﹤0.01% |
51,774
-18,486
| -26% | -$312K |
|
2106
Vanda Pharmaceuticals
VNDA
$268M
| $874K | ﹤0.01% |
190,365
-113,781
| -37% | -$522K |
|
2107
Full Truck Alliance
YMM
$14.2B
| $873K | ﹤0.01% |
68,329
-762,694
| -92% | -$9.74M |
|
2108
Aldeyra Therapeutics
ALDX
$329M
| $872K | ﹤0.01% |
151,642
-36,941
| -20% | -$212K |
|
2109
eXp World Holdings
EXPI
$1.78B
| $872K | ﹤0.01% |
+89,142
| New | +$872K |
|
2110
LendingTree
TREE
$979M
| $871K | ﹤0.01% |
17,323
-6,554
| -27% | -$329K |
|
2111
Vital Energy
VTLE
$644M
| $870K | ﹤0.01% |
41,002
-118,249
| -74% | -$2.51M |
|
2112
CEVA Inc
CEVA
$564M
| $870K | ﹤0.01% |
33,968
-57,168
| -63% | -$1.46M |
|
2113
Donegal Group Class A
DGICA
$712M
| $868K | ﹤0.01% |
44,194
-1,284
| -3% | -$25.2K |
|
2114
HighPeak Energy
HPK
$908M
| $867K | ﹤0.01% |
68,494
+17,052
| +33% | +$216K |
|
2115
Entravision Communication
EVC
$225M
| $864K | ﹤0.01% |
411,327
-42,254
| -9% | -$88.7K |
|
2116
Immunovant
IMVT
$2.87B
| $864K | ﹤0.01% |
50,534
-17,135
| -25% | -$293K |
|
2117
Wave Life Sciences
WVE
$1.12B
| $861K | ﹤0.01% |
106,554
-609,699
| -85% | -$4.93M |
|
2118
Hanover Insurance
THG
$6.46B
| $860K | ﹤0.01% |
+4,946
| New | +$860K |
|
2119
iShares MSCI Japan Small-Cap ETF
SCJ
$149M
| $857K | ﹤0.01% |
11,169
| – | – |
|
2120
Adeia
ADEA
$1.71B
| $855K | ﹤0.01% |
+64,704
| New | +$855K |
|
|
UCB
2121
United Community Banks, Inc.
UCB
$3.96B
| $855K | ﹤0.01% |
+30,391
| New | +$855K |
|
2122
Orthofix Medical
OFIX
$601M
| $854K | ﹤0.01% |
52,380
+6,221
| +13% | +$101K |
|
2123
Nicolet Bankshares
NIC
$2.01B
| $851K | ﹤0.01% |
7,810
+4,149
| +113% | +$452K |
|
2124
Rivian
RIVN
$16B
| $850K | ﹤0.01% |
+68,246
| New | +$850K |
|
2125
AvidXchange
AVDX
$2.06B
| $848K | ﹤0.01% |
+100,037
| New | +$848K |
|